---
title: "300452.SZ (300452.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300452.SZ/news.md"
symbol: "300452.SZ"
name: "300452.SZ"
parent: "https://longbridge.com/en/quote/300452.SZ.md"
datetime: "2026-05-20T22:44:40.409Z"
locales:
  - [en](https://longbridge.com/en/quote/300452.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300452.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300452.SZ/news.md)
---

# 300452.SZ (300452.SZ) — Related News

### [SUNHERE: In 2025, net profit is expected to increase by 47.84% year-on-year, proposing a dividend of 3 yuan for every 10 shares](https://longbridge.com/en/news/283680135.md)
*2026-04-22T13:53:47.000Z*
> SUNHERE disclosed in its annual report that the operating revenue for 2025 is expected to be 943 million yuan, a year-on

### [SUNHERE: The company successfully passed the on-site inspection by the U.S. FDA](https://longbridge.com/en/news/274780703.md)
*2026-02-04T08:35:33.000Z*
> SUNHERE announced that the company underwent an on-site inspection by the U.S. Food and Drug Administration (FDA) from D

### [SUNHERE expects a profit increase, with a projected year-on-year growth of 38.16%-62.45% in net profit attributable to the parent company for the fiscal year 2025](https://longbridge.com/en/news/272520836.md)
*2026-01-14T08:29:03.000Z*
> SUNHERE expects the net profit attributable to the parent company for the fiscal year 2025 to be between 165 million yua

### [SUNHERE's shareholder FOSUN PHARMA plans to reduce its holdings by no more than 3%](https://longbridge.com/en/news/263770825.md)
*2025-10-31T14:21:02.000Z*
> According to the announcement from Dolphin Research, SUNHERE announced that its shareholder Shanghai FOSUN PHARMA Indust

### [SUNHERE released its performance for the first three quarters, with a net profit attributable to the parent company of 133 million yuan, an increase of 8.28%](https://longbridge.com/en/news/261838041.md)
*2025-10-20T08:45:03.000Z*
> According to the Zhitong Finance APP, SUNHERE released its third-quarter report for 2025. The company's operating revenu

### [300452, the original actual controller's spouse and daughter inherit stocks worth 800 million](https://longbridge.com/en/news/259416954.md)
*2025-09-29T23:49:33.000Z*
> SUNHERE (300452) The new actual controller has emerged. The company disclosed on the evening of September 29 that due to

### [SUNHERE: The controlling shareholder and actual controller has changed from Yin Zhenglong to Wu Changhong](https://longbridge.com/en/news/259338567.md)
*2025-09-29T12:19:28.000Z*
> SUNHERE announced that the controlling shareholder and actual controller has changed from Yin Zhenglong to Wu Changhong.

### [SUNHERE released its performance for the first half of the year, with a net profit attributable to the parent company of 93.0352 million yuan, a decrease of 2.61%](https://longbridge.com/en/news/254574867.md)
*2025-08-26T08:30:04.000Z*
> According to the Zhitong Finance APP, SUNHERE released its semi-annual report for 2025, showing that the company's opera

### [SUNHERE has added 1 new pharmaceutical excipient product](https://longbridge.com/en/news/251409683.md)
*2025-08-04T08:39:04.000Z*
> According to the Zhitong Finance APP, SUNHERE announced that the company has added a new pharmaceutical excipient produc